CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Investors›
3E Bioventures Capital
Location
Beijing, CN
Founded
2015
Firm
Compare
Portfolio
Employees
Library

3E Bioventures Capital is a life science-focused venture fund investing in global health innovators. The firm concentrates on biotech, including new drugs, modalities, and drug discovery platforms, as well as TechBio, the intersection of biology and technology. Their investments span various stages, with a particular emphasis on Series A and B rounds.

The firm adopts a science-driven, entrepreneur-friendly investment philosophy, working closely with companies and research institutions. Notable portfolio companies include Ansun Biopharma, Dewpoint Therapeutics, and Cullgen. 3E Bioventures Capital offers expertise, efficiency, and execution to support their investments in transformative healthcare solutions.

3E Bioventures Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Portfolio Companies14
Follow-on Investments5
Current Portfolio Count14

Top Investment Stages

Series A8 (42.1%)
Series B8 (42.1%)
Series C3 (15.8%)

Stage Mix

Recent Investments

Myrobalan Therapeutics logo

Myrobalan Therapeutics

Larkspur Biosciences logo

Larkspur Biosciences

Regenacy Pharmaceuticals logo

Regenacy Pharmaceuticals

Dewpoint Therapeutics logo

Dewpoint Therapeutics

Dermaliq Therapeutics logo

Dermaliq Therapeutics

Alebund Pharmaceuticals logo

Alebund Pharmaceuticals

Cullgen logo

Cullgen

Subtle Medical logo

Subtle Medical

C4 Therapeutics logo

C4 Therapeutics

Lipidio Pharmaceuticals logo

Lipidio Pharmaceuticals

Ansun Biopharma logo

Ansun Biopharma

Cytek Biosciences logo

Cytek Biosciences

Profusa logo

Profusa

Refuge Biotechnologies logo

Refuge Biotechnologies

3E Bioventures Capital - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
3E Bioventures Capital logo

3E Bioventures Capital

Operating Status: Operating

3E Bioventures Capital: A healthcare-focused venture fund investing in drugs, devices, diagnostics, and IT services.

Series A 42%Series B 42%Series C 16%

Concentration shown as share of disclosed investments by stage.

3E Bioventures Capital - Similar Investment Firms

30Ventures logo

30Ventures

E3 Capital Partners logo

E3 Capital Partners

e3capital.co

BioVenture logo

BioVenture

bioventure.com.cn

S3 Ventures logo

S3 Ventures

s3vc.com

Bioventures Investors logo

Bioventures Investors

Bioeconomy Capital logo

Bioeconomy Capital

Posco Bioventures logo

Posco Bioventures

E-Ventures logo

E-Ventures

Third Rock Ventures logo

Third Rock Ventures

EVX Ventures logo

EVX Ventures

evx.ventures

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Solas BioVentures logo

Solas BioVentures

solasbio.com

Eagle Venture Fund logo

Eagle Venture Fund

Seae Ventures logo

Seae Ventures

305 Ventures logo

305 Ventures

305.ventures